题名 | The role of KPNA2 as a monotonically changing differentially expressed gene in the diagnosis, risk stratification, and chemotherapy sensitivity of chronic hepatitis B-liver cirrhosis-hepatocellular carcinoma |
作者 | |
发表日期 | 2023-11 |
发表期刊 | Journal of cancer research and clinical oncology 影响因子和分区 |
语种 | 英语 |
原始文献类型 | Journal Article |
关键词 | Biomarker Diagnosis Hepatocellular carcinoma Karyopherin subunit alpha 2 Risk stratification |
其他关键词 | KARYOPHERIN-ALPHA 2 ; CANCER ; BIOMARKER ; MARKER |
摘要 | Chronic hepatitis B-liver cirrhosis-hepatocellular carcinoma (CLH), commonly called the "liver cancer trilogy", is a crucial evolutionary phase in the emergence of hepatocellular carcinoma (HCC) in China. Previous studies on early diagnostic biomarkers of HCC were limited to the end-stage of HCC and did not focus on the evolutionary process of CLH., 11 monotonically changing differentially expressed genes (MCDEGs) highly correlated with CLH were screened through bioinformatic analysis and KPNA2 was identified for further research. The serum KPNA2 expression in different CLH states was detected by Enzyme linked immunosorbent assay (ELISA). A nomogram model was constructed using univariate and multivariate Cox regression methods., {AbstractText=The single-cell RNA-seq and bulk RNA-seq revealed that KPNA2 related to immune infiltration in HCC and may participate in cell cycle pathways in HCC. The serum KPNA2 expression was monotonically upregulated in CLH and was valuable for diagnosing different CLH states. Besides, chronic hepatitis B(CHB) patients, liver cirrhosis (LC) patients, and HCC patients were classified into subgroups with distinct serum KPNA2 expressions. Accordingly, patients with different serum KPNA2 expressions displayed various clinicopathological features. The AUC value of the nomogram model was 0.959 in predicting the likelihood of developing HCC in CHB patients or LC patients. Finally, we found that KPNA2 expression was negatively correlated with the IC50 of four chemotherapeutic drugs in HCC.}, KPNA2 was a novel serum biomarker for diagnosing different CLH states, monitoring the dynamic evolution of CLH, and a new therapeutic target for intervening in the progression of CLH. |
资助项目 | General Scientific Research Project of Zhejiang Provincial Education Department[Y202250086] ; Zhejiang Province Major Science and Technology Project for Medicine and Health[WKJ-ZJ-2329] |
出版者 | SPRINGER |
ISSN | 0171-5216 |
EISSN | 1432-1335 |
卷号 | 149期号:15页码:13753-13771 |
DOI | 10.1007/s00432-023-05213-z |
页数 | 19 |
WOS类目 | Oncology |
WOS研究方向 | Oncology |
WOS记录号 | WOS:001040920400001 |
收录类别 | SCIE ; PUBMED ; SCOPUS |
在线发表日期 | 2023-08 |
URL | 查看原文 |
发表状态 | 已发表 |
PubMed ID | 37526663 |
SCOPUSEID | 2-s2.0-85166335213 |
通讯作者地址 | [Li, Shibo]Department of Infectious Disease,Zhoushan Hospital,Wenzhou Medical University,739 Dingshen Rd,Zhoushan City,316021,China |
Scopus学科分类 | Oncology;Cancer Research |
引用统计 | |
文献类型 | 期刊论文 |
条目标识符 | https://kms.wmu.edu.cn/handle/3ETUA0LF/181788 |
专题 | 其他_附属舟山医院(舟山医院) |
通讯作者 | Li, Shibo |
作者单位 | 1.Department of Infectious Disease,Zhoushan Hospital,Wenzhou Medical University,739 Dingshen Rd,Zhoushan City,316021,China; 2.Pathological Diagnosis Center,Zhoushan Hospital,Wenzhou Medical University,739 Dingshen Rd,Zhoushan City,316021,China; 3.State Key Laboratory for the Diagnosis and Treatment of Infectious Diseases,The First Affiliated Hospital,Zhejiang University School of Medicine,79 Qingchun Rd,Hangzhou City,310003,China |
第一作者单位 | 其他_附属舟山医院(舟山医院) |
通讯作者单位 | 其他_附属舟山医院(舟山医院) |
第一作者的第一单位 | 其他_附属舟山医院(舟山医院) |
推荐引用方式 GB/T 7714 | Pan, Yong,Zhang, Yiru,Lu, Zhengmei,et al. The role of KPNA2 as a monotonically changing differentially expressed gene in the diagnosis, risk stratification, and chemotherapy sensitivity of chronic hepatitis B-liver cirrhosis-hepatocellular carcinoma[J]. Journal of cancer research and clinical oncology,2023,149(15):13753-13771. |
APA | Pan, Yong, Zhang, Yiru, Lu, Zhengmei, Jin, Danwen, & Li, Shibo. (2023). The role of KPNA2 as a monotonically changing differentially expressed gene in the diagnosis, risk stratification, and chemotherapy sensitivity of chronic hepatitis B-liver cirrhosis-hepatocellular carcinoma. Journal of cancer research and clinical oncology, 149(15), 13753-13771. |
MLA | Pan, Yong,et al."The role of KPNA2 as a monotonically changing differentially expressed gene in the diagnosis, risk stratification, and chemotherapy sensitivity of chronic hepatitis B-liver cirrhosis-hepatocellular carcinoma".Journal of cancer research and clinical oncology 149.15(2023):13753-13771. |
条目包含的文件 | 下载所有文件 | |||||
文件名称/大小 | 文献类型 | 版本类型 | 开放类型 | 使用许可 | ||
原文.pdf(10192KB) | 期刊论文 | 作者接受稿 | 开放获取 | CC BY-NC-SA | 浏览 下载 |
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。
修改评论